Clinical StudyEffect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease*
References (31)
- et al.
The effect of nitroglycerin on coronary blood flow and the hemodynamic response to exercise in coronary artery disease
Am J Cardiol
(1971) - et al.
The effects of nitroglycerin on myocardial blood flow in man. Measured by coincidence counting and bolus injections of 84rubidium
Am J Cardiol
(1969) - et al.
Physiologic and clinical actions of nitroglycerin
Med Clin North Am
(1974) - et al.
Measurement of regional myocardial blood flow in man: description and critique of the method using xenon-133 and a scintillation camera
Am J Cardiol
(1975) - et al.
Comparison of biplane and single plane left ventriculograms in patients with coronary artery disease
Am J Cardiol
(1974) - et al.
Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment
Am J Cardiol
(1975) - et al.
Regional myocardial blood flow during contrast agent hyperemia in patients with coronary artery disease
Am J Cardiol
(1976) - et al.
Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work
Circulation
(1959) - et al.
The effect of nitroglycerin on the systemic circulation in man and dog
Circulation
(1966) - et al.
The determination of coronary flow equivalent with coincidence counting technique
Circulation
(1964)
Failure of intracoronary nitroglycerin to alleviate pacing-induced angina
Circulation
Myocardial blood flow in coronary artery disease. Effect of right atrial pacing and nitroglycerin
Circulation
Localized disorders in myocardial contraction. Asynergy and its role in congestive heart failure
N Engl J Med
Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations
Circulation
Measuring regional myocardial blood flow with 133Xe and the Anger camera
Radiology
Cited by (71)
Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure
2017, American Journal of Emergency MedicineCitation Excerpt :In fact, 2 patients in the bolus group had initial blood pressures of 84/55 and 96/69 received 1 and 2 mg of bolus nitroglycerin with no adverse events. This was potentially a concern with the use of high doses of nitroglycerin given that previous evidence indicated a decrease in myocardial blood flow in patients with coronary heart disease given sublingual nitroglycerin [13] Combined with prior literature [10,12], our results suggest that bolus nitroglycerin can be safely used alone or in combination with standard continuous infusion of IV nitroglycerin in patients with AHF. This study has several limitations.
Assessment of Coronary Vasodilatation in Response to Nitroglycerin with Transthoracic Doppler Echocardiography
2006, Journal of the American Society of EchocardiographyImproved detection of myocardial perfusion reversibility by rest-nitroglycerin Tc-99m-MIBI: Comparison with Tl-201 reinjection
1999, Journal of Nuclear CardiologyTransthoracic echocardiographic measurement of coronary blood flow and reserve
1997, Journal of the American Society of EchocardiographyNitrate-augmented myocardial imaging for assessment of myocardial viability
1995, Journal of Nuclear Cardiology
- *
This study was supported by Grants HL 11306, HL 7049, HL 11668 and GM0 18674 from the U.S. Public Health Service, Bethesda, Maryland.